The Online Investor

Slideshow Stock Splits

By The Online Investor Staff, updated Mon., Nov. 11, 10:04 PM

Slide #3. Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) 1 for 10 Reverse Split

Announced: 10/31/2019
Stock Split: 1 for 10
Record Date: 10/31/2019
Pay Date: 11/1/2019
TNXP Optionable?: No

Tonix Pharmaceuticals Holding is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Co.'s main drug development program is focused on delivering a long-term treatment for posttraumatic stress disorder. Co.'s primary product candidate, Tonmya, or TNX-102 SL, is a proprietary low-dose cyclobenzaprine sublingual tablet, designed for bedtime administration. TNX-102 SL is also being developed as a bedtime treatment for Fibromyalgia, and agitation in Alzheimer's disease.
TNXP Detailed Information Page & Split History »

Company Name: 
Tonix Pharmaceuticals Holding Corp
Stock buyback: 
TNXP buyback
Website: 
www.tonixpharma.com;www.tonix.com;www.krele.com
Sector: 
Biotechnology
Number of ETFs Holding TNXP: 
1
Total Market Value Held by ETFs: 
$15
Total Market Capitalization: 
$4.00M
% of Market Cap. Held by ETFs: 
0.00%

Open the TNXP Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
80th percentile
(ranked higher than approx. 80% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Stock Splits Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2019, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.